Pixium Vision Complete Reverse Stock Split

Pixium Vision announced the completion of a reverse stock split, as decided by its Board of Directors on July 27, 2023, on the basis of 1 new share for 50 existing shares. Shareholders who could not hold a multiple of 50 existing shares will be automatically compensated of their fractional shares by their financial intermediary within 30 days.

Pixium is the maker of the Prima System sub-retinal miniature photovoltaic wireless implant, which is in clinical testing for patients who have lost their sight due to outer retinal degeneration, initially for atrophic dry age-related macular degeneration (AMD).

After the announcement of a shareholder loan of €3 million from Bpifrance Participations and Sofinnova Capital VII on July 28, 2023, the Pixium confirmed the cash runway until the end of November 2023. The company continues to actively seek financing options to support its strategic ambitions.